CANSCAN Trial of AVF Mapping With VxWave Ultrasound Imaging System Completes Enrollment - Endovascular Today

Vexev and U.S. Renal Care Complete Enrollment in Groundbreaking Trial Evaluating Use of Robotic Ultrasound Scanning for AV Fistula Mapping in Dialysis Clinics

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin CANSCAN study enrolled 120 patients with chronic kidney disease using the investigational, semi-autonomous VxWave Ultrasound Imaging System The VxWave Ultrasound Imaging System potentially provides important insights into vascular access, to possibly enable earlier creation and use of AV fis…

CANSCAN Trial of AVF Mapping With VxWave Ultrasound Imaging System Completes Enrollment - Endovascular Today

July 29, 2025—Vexev and U.S. Renal Care announced the completion of enrollment in the CANSCAN clinical trial, a multicenter feasibility study evaluating the use of semiautonomous ultrasound scanning with Vexev’s VxWave system for arteriovenous fistula (AVF) mapping in dialysis clinics. Vexev is an Australian-based medical device company focused on vascular imaging, and U.S. Renal Care is a United States provider of in-center and home dialysis. T…